|
mutLBSgeneDB |
| |
| |
| |
| |
| |
| |
|
| Gene summary for CDC14B |
 Gene summary |
| Basic gene Info. | Gene symbol | CDC14B |
| Gene name | cell division cycle 14B | |
| Synonyms | CDC14B3|Cdc14B1|Cdc14B2|hCDC14B | |
| Cytomap | UCSC genome browser: 9q22.3 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001077181.1, NM_003671.3,NM_033331.2,NM_033332.1, | |
| Description | CDC14 cell division cycle 14 homolog Bdual specificity protein phosphatase CDC14B | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 603505 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000081377 | ||
| HPRD : 04615 | ||
| Vega : OTTHUMG00000020300 | ||
| Protein | UniProt: O60729 go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_CDC14B | |
| BioGPS: 8555 | ||
| Pathway | NCI Pathway Interaction Database: CDC14B | |
| KEGG: CDC14B | ||
| REACTOME: CDC14B | ||
| Pathway Commons: CDC14B | ||
| Context | iHOP: CDC14B | |
| ligand binding site mutation search in PubMed: CDC14B | ||
| UCL Cancer Institute: CDC14B | ||
| Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. | |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO Term | PubMed ID | GO:0031572 | G2 DNA damage checkpoint | 18662541 | GO:0035335 | peptidyl-tyrosine dephosphorylation | 9367992 |
| Top |
| Ligand binding site mutations for CDC14B |
| Cancer type specific mutLBS sorted by frequency |
| LBS | AAchange of nsSNV | Cancer type | # samples | F85 | N84I | BLCA | 1 | R320 | T321M | UCEC | 1 |
| cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
| Top |
| Protein structure related information for CDC14B |
| Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
 : nsSNV at non-LBS : nsSNV at LBS |
 |
| nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
| LBS | AAchange of nsSNV | Relative stability change | R320 | T321M | 0.15956611 | F85 | N84I | -0.23304409 |
| (MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
| Structure image for CDC14B from PDB |
| Top |
| Differential gene expression and gene-gene network for CDC14B |
| Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
| Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
| Top |
| Top |
| Phenotype information for CDC14B |
| Gene level disease information (DisGeNet) |
| Disease ID | Disease name | # PubMed | Association type |
| Mutation level pathogenic information (ClinVar annotation) |
| Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
| Top |
| Pharmacological information for CDC14B |
| Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
 |
| Drug information targeting mutLBSgene (Approved drugs only) |
| Drug status | DrugBank ID | Name | Type | Drug structure |
| Gene-centered ligand-gene interaction network |
 |
| Ligands binding to mutated ligand binding site of CDC14B go to BioLip |
| Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | III | Peptide ligand (ACE,ALA,SER,PRO) | 1ohe | A | F85 R320 | WO4 | TUNGSTATE | 1ohd | A | R320 |
| Top |
| Conservation information for LBS of CDC14B |
| Multiple alignments for O60729 in multiple species |
| LBS | AA sequence | # species | Species |
 |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |